NCT06654999View on ClinicalTrials.gov

How Consistent is the Output of DERM, When Used to Assess Images of Potentially Cancerous Skin Lesions.

CompletedOBSERVATIONAL

Enrollment

115

Participants

Timeline

Start Date

December 18, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions

Skin CancerMelanoma of SkinSquamous Cell CancerBasal Cell Cancer

Interventions

DEVICE

Deep Ensemble for the Recognition of Malignancy (DERM)

"DERM variants + and DS"

Trial Locations (3)

Unknown

Norwich and Norfolk Hospitals Trust, Norwich

University Hospitals Dorset, Poole

Surrey and Sussex Hospital Trust, Redhill

All Listed Sponsors

lead

Skin Analytics Limited

INDUSTRY

NCT06654999 - How Consistent is the Output of DERM, When Used to Assess Images of Potentially Cancerous Skin Lesions. | Biotech Hunter | Biotech Hunter